15
Preliminary Program
8:00 am Welcome and Introduction – Eric D. Donnenfeld, MD
8:10 am The Refractive Impact of Ocular Surface Disease – Francis S. Mah, MD
8:20 am Streamlining OSD Diagnosis and Treatment in Preoperative Patients
– Christopher E. Starr, MD
8:35 am Panel Discussion
8:40 am Diagnosing Ocular Surface Disease in the Preoperative Patient
– Preeya K. Gupta, MD
8:52 am Treating the Ocular Surface in the Preoperative Patient
– Marjan Farid, MD
9:05 am Panel Discussion
9:10 am Pairing Therapeutics with Diagnosis: What Would You Do? – All faculty
9:25 am Conclusions
9:30 am Adjourn
Supported by educational grants from Allergan Inc., Johnson & Johnson Vision,
Sun Ophthalmics, and Shire. Additional grants pending.
Registration is available onsite!
Notice of Off-Label Use Presentations
This program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug
Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to
determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of
medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of
the uses, products, or techniques presented.
ADA/Special Accommodations
ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also
requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodations
or services should contact an ASCRS or EyeWorld staff member onsite.
